Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Agreed. Having shares held by Israeli ETFs that won't lend them is nice...
The sun is rising thru the morning mist...
TASE index inclusion next Sunday: upcoming buying pressure
Lixumia is not a prandial insulin, and GLP-1 are known for their weight loss effect.
Interestingly, Afrezza use was also linked to weight loss compared to injectable prandial insulins during Phase 3.
Afrezza complements well Hamni's deal:
With Hamni, Sanofi is looking for successors to Toujeo and Lixumia.
Afrezza is unique.
Agreed, some here still don't know the difference between fast acting prandial insulin and basal insulin...
MNKD 10th consecutive day on Fail-to-deliver list...
Shares for sale flood the market but are not delivered...
Would naked shorting be endemic ?
Shorts are playing musical chairs... which bear will be the (big) loser stuck with the short position ?
Amusing timing for a downgrade...
Good find Adnan's extremely low analyst ranking
Indeed shorts are scared to death !!! 124 M shorted shares to cover while the free float is only 255 M and Israeli funds are knocking at the door for shares...
Then, there are the 105 M shares in calls (18 M of which at or below $3.00) that could be exercised for delivery anytime...
18M+ shares in calls below $3.00 strike. Where are the shares if delivery is requested ?
Shorts are playing musical chairs... which bear will be the (big) loser stuck with the short position ?
MNKD 9th consecutive day on Fail-to-deliver list...
Shares for sale flood the market but are not delivered...
Would naked shorting be endemic ?
Shorts are playing musical chairs... which bear will be the (big) loser stuck with the short position ?
The perfect storm: hail of FUD articles thrown onto MNKD to distract investors from:
- increasing naked shorts and fail-to-deliver
- increasing share demand from Israel,
- decreasing number of shares available for loan to shorts,
- increasing Rx for Afrezza, and
- improving formulary placement for Afrezza.
Good omen: quarterly results on Monday, giving more time for markets to react to good news over the week
Evidenced as increasing Rx and improved formulary placement.
MNKD 8th consecutive day on Fail-to-deliver list...
Shorts are playing musical chairs... which bear will be the (big) loser stuck with the short position ?
Short raid ongoing: desperate try to kill growing positive momentum in the egg.
MNKD 7th consecutive day on Fail-to-deliver list...
Shorts are playing musical chairs... which bear will be the (big) loser stuck with the short position ?
Spooky shorts' Halloween: 627 TRx, 421 NRx (2 firsts on the same week !)
In yesterday's bear raid maybe some smart shorts covered, but what about those who sold to them...
What a spooky Halloween for shorts !
Musical chairs ongoing: who will get caught short when the music stops...
This morning incredible rates to borrow shares were offered by shorts, preparing for the next attack...
Seems like they need to trash the PPS to cover.
Talking about bad advice: New trash article out by the street with nasty headline. What a surprise !
MNKD 6th consecutive day on Fail-to-deliver list, will it beat last Spring's 15 days series ?
$2.40 warrants used to return borrowed shares IMO...
On Jun 30, only 4.1 M warrants at $2.40 were left. Their number had been decreasing steeply q/q over 2015.
No doubt the total will near 0 on Sep 30, as this was the easiest way to repay borrowed shares...
short interest: 50% free float heralds shorts' trouble...
124.0 M short interest on 250.5 M free float (414.0 M shares outstanding - Al's 154.5 M - BoA returned 9.0 M)
9M BoA shares returned, MNKD borrowing becomes harder...
MannKind Announces Termination of Stock Lending Agreement
Gigantic call open interest and massive call trading yesterday as you point (9 M in Nov's, 4.5 M in Jan 16's, 8 M in Feb 16's, ...) herald lots of trouble for bears (shorts n call sellers).
Last time this happened in the Spring, I recall reading that many ITM calls were exercised, thus adding to the demand for shares...
A nightmarish Halloween for shorts in perspective !!!!
I feel good
MNKD back on fail-to-deliver list, reminds you of something ?
Amusing how fast this happens following little moves up...
As of Oct 21 close, MNKD made it back to the fail to deliver list:
- for five consecutive settlement days,
- aggregate fails to deliver at a registered clearing agency of at least one-half of one percent of the issuer’s total shares outstanding = 2,070,000 shares.
Reg SHO threshold list
Goldberg/ Troup choosing shares over worthless cash again and again...
Always interesting when directors prefer being paid in shares instead of cash.
Interesting, IMS NRx over 300 for the 1st time.
IMS and Symphony data continue to mirror each other and trend up...
FYI, call contracts are for 100 shares each. Just saying in case you would like to play with options...
Quote:
"Oh, by the way, I looked at all the open interest Call contracts sold out to 2018. Roughly counting all Calls at $7 and below (not just below $7 as you stated), I can only account for roughly 500-Thousand contracts, and that is nowhere near 104-Million Calls. Hell, it's not even One-Million. "
So, "roughly" 500,000 calls contracts are for "roughly" 50 M calls, which is in the ballpark of the 65-70 M calls below $7.00 I mentioned...
If you really sum the OI to $7.00, 675,411 contracts are open for 67.5 M calls.
BoA 1 week left to return 9 million shares...
clock ticking down fast...
shorts also fear losing on 104 M calls written, 1/2 of them below $5.00 and 2/3 below $7.00...
this could get messy for shorts pretty fast...
Why would failing in clinic be management fault, all the more when the partner was responsible... ?
"Pfizer informed the Company that the product Pfizer was developing failed to meet pre-specified endpoints in a clinical study".
same FUD, now hidden behind a self-referring post...
Agreed, pretty good update for the time given.
Confirmation of debt dealing was important, as it was still being used as FUD only a few days ago...
Interesting hints of coming positive developments on launch, label, milestones.
follow-up last week's article, note small layoffs consistent with announced streamlining of operations made in last 2 conf calls...
Amusing volley of negative posts, what frightens you so much ?
re-re-re-heated old FUD....
Comparison with Boeing does not fly...
Same old same old: a Feuerstein attack piece, never realized it had already been a week since last...
Possible if BoA doesn't returns 9 M shares to MNKD
ethically, BoA has toyed with bankruptcy for a long time...
BoA must return 9,000,000 shares soon...
$32 M in old convertible notes were exchanged for new convertible notes on Aug 13.
This means the old convertible became due on Aug 15 in its entirety and is now extinguished...
The clock is ticking for Bank of America
Interesting Monday: Resident doom-sayer bullish on MNKD since Friday close above $3.25...